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Glycan recognition leading to cell-cell interactions,
signaling, and immune responses ismediated by var-
ious glycan-binding proteins (GBPs) showing highly
diverse ligand specificities. We describe here a rapid
glycan immobilization technique via 4-hydrazinoben-
zoic acid (HBA)-functionalized beads and its applica-
tion to high-throughput screening of miniature pig
kidney N-glycan-binding proteins by using a mass-
spectrometric approach. Without any derivatization
steps, the purified pig kidneyN-glycans were directly
immobilized on to HBA-functionalized beads and
subsequently used to identify GBPs from human
serum. This screening method showed remarkable
performance for identifyingpotentialGBPsclosely in-
volved in pig-to-human xenograft rejection mediated
by human serum, including antibodies, cytokines,
complement components, siglec, and CD antigens.
Thus, these results demonstrate that theGBPscreen-
ingmethodwasfirmly establishedbyone-step immo-
bilization of the N-glycans on to microsphere and
highly sensitive mass-spectrometric analysis.
INTRODUCTION
Eukaryotic cell surfaces are very rich in glycoconjugates, such as
complex N- and O-glycans, on glycoproteins or glycolipids
(Varki, 1999). The expressed glycans not only affect the stability
and solubility of proteins, but also protect proteins from proteol-
ysis (Taylor and Drickamer, 2003). In addition, the extracellular
glycosylation is mainly involved in cell-protein and cell-cell inter-
action followed by various immunological events (Rudd et al.,Chemistry & Biology 12001; Paulson et al., 2006). In xenotransplantation, the interac-
tion between a nonhuman glycan highly expressed on pig endo-
thelial cells (e.g., Gala1,3Gal, abbreviated to Gal) and human
xenoreactive natural antibodies or lectins induces hyperacute
immune response resulting in rapid graft failure (Oriol et al.,
1993). In spite of production of a1,3-galactosyltransferase
gene-knockout (GT-KO) pigs that do not express Gal, specific
interactions between non-Gal antigens on the pig cells and their
glycan-binding proteins (GBPs) from human serum still induce
acute humoral xenograft rejection (Kuwaki et al., 2005). The iden-
tification of GBPs in human serum other than natural antibodies
that are responsible for cell-surface sugar recognition will pro-
vide information that may resolve the problems of the innate
and adaptive immune responses to xenografts and will provide
insight into the development of improved strategies to achieve
successful xenotransplantation.
The development of efficient analytical GBP screening
methods toward specific glycan motifs, however, has been
difficult owing to a very low affinity (in the range of mM to mM)
of GBP-glycan binding (Collins and Paulson, 2004) and the lack
of well-characterized glycan libraries. In addition, highly-sensi-
tive analytical tools are required to identify low-abundant GBPs
in real biological systems. Recently, several attempts to use gly-
can array formats (Blixt et al., 2004; Xia et al., 2005; Adams et al.,
2004; Fazio et al., 2002; Houseman andMrksich, 2002; Park and
Shin, 2002; Ratner et al., 2004) to determine glycan specificities
and candidate ligands of theGBPshavebeen reported, but these
microarray-based approaches are not suitable for screening of
unknown GBPs from diverse protein sources, such as human
serum. In themicroarray format, relevant information anticipating
the matches between specific GBPs and glycans is required for
detection of the screened GBPs by using GBP-specific primary
and secondary antibodies (Blixt et al., 2004; Adams et al., 2004).
To covalently immobilize glycans on to polymeric solid sup-
ports, glycan can be derivatized to appropriately activated5, 215–223, March 2008 ª2008 Elsevier Ltd All rights reserved 215
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(Fazio et al., 2002), and cyclopentadiene (Houseman and
Mrksich, 2002). However, the conventional glycan-immobiliza-
tion methods inevitably require laborious and time-consuming
purification steps to remove unreacted glycans, chemicals,
and byproducts during glycan derivatization. Moreover, they
are limited to the immobilization of monosaccharides and short
oligosaccharides because of their restrictive site specificity
and poor reactivity. Renaudet et al. reported resin-based carbo-
hydrate immobilization method for high-throughput screening of
multivalent protein-carbohydrate interactions (Renaudet and
Dumy, 2005, 2006). Although the resin-bound carbohydrate
probes are quite applicable to the rapid discovery of new selec-
tive carbohydrate-based ligands, the chemoselective oxime
ligation with solid supports inevitably requires the aminooxy-
derivatized carbohydrates.
Herein, we developed a versatile one-step glycan immobiliza-
tionmethod to covalently immobilize the free reducing part of the
glycan site specifically. The method was directly applied to rapid
and high-throughput GBP screening with highly sensitive mass
spectrometry. Without any derivatization steps, a 4-hydrazino-
benzoic acid (HBA)-containing hydrazide group was introduced
on to core-shell-type beads prior to the immobilization of the
underivatized free glycans (Figure 1). The glycan-HBA beads
that present the immobilized glycans might mimic a cell-surface
covered by glycoconjugates, allowing direct interactions with
other cells or proteins. Furthermore, the direct immobilization
of unmodified oligosaccharides gives significant advantages
over the other conventional methods from an operational point
of view, especially when working with complex glycans available
from natural sources. The directional conjugations of linear oligo-
saccharides and chicken ovalbumin N-glycans on to HBA-func-
tionalized beads were carried out as model systems, and their
correct attachments to the bead surface were demonstrated
by using MALDI-TOF MS and specific lectins. Finally, the spe-
cific pathogen-free ChicagoMedical School miniature pig kidney
N-glycan-immobilized beads were applied to high-throughput
screening of specific GBPs from human serum followed by
mass spectrometry. In this study, a LTQ Orbitrap hybrid Fourier
Transform Mass Spectrometer (LTQ Orbitrap FT MS) that pro-
vides high mass accuracy and sensitivity was used to identify
low-abundant GBPs in human serum. To the best of our knowl-
Figure 1. One-Step Conjugation of the
Free N-Glycans with 4-Hydrazinobenzoic
Acid-Functionalized Beads
edge, heteromixtures of completely natu-
ral glycan conjugates have not been used
for screening of GBPs from human serum
previously.
RESULTS AND DISCUSSION
To conjugate free reducing glycans
through a one-step reaction on to beads,
a b-Ala-3-aminocaproic acid-b-Ala-3-
aminocaproic acid (BEBE)-photolabile
linker (PLL) was built up by using a 9-fluorenylmethyloxycarbo-
nyl(Fmoc)/tBu strategy on to the HiCore resin (see the Supple-
mental Data available with this article online; Lee et al., 2007),
which structure is a core-shell-type and shows a low level of
nonspecific binding of proteins (Kim et al., 2004, 2006a). N-t-
butyloxycarbonyl (N-Boc)-protected HBA (N-Boc-HBA), i.e., a
chemoselective anchoring agent, was directly conjugated with
BEBE-PLL-resin, and trifluoroacetic acid (TFA) was used for the
deprotection of theBocgroup. Various glycanswere immobilized
on the functionalized beads via Schiff base reaction between the
aldehyde group at the reducing end of the N-glycans and the hy-
drazide group of HBA-conjugated beads under mild acidic con-
ditions and subsequent cyclization reaction (Lee andShin, 2005).
To validate the immobilization of free N-glycans on to HBA-
functionalized beads, a commercially available tetrasaccha-
ride, N,N0,N00,N00 0-tetraacetylchitotetraose (GlcNAc4, GlcNAcb1-
4GlcNAcb1-4GlcNAcb1-4GlcNAc), was used, which has the
same reducing N-acetylhexosamine residue as free N-glycans.
Every individual step of the synthesis of glycan-HBA bead con-
struction was directly confirmed by the expected mass spectra
of the released synthetic product by using MALDI-TOF MS and
PLL linker (Figure 2A; Kim et al., 2007). The major peaks at m/z
408.2 (BEBE) and 642.0 (Boc-HBA-BEBE) in the form of
[M+Na]+ indicated the sequential order of HBA-functionalized
bead synthesis. After deprotection with TFA, the GlcNAc4 was
coupled with HBA-functionalized beads under a mild acidic con-
dition, and the intact mass at m/z 1354.7 (GlcNAc4-HBA-BEBE)
exactly matched our calculated value. To our knowledge, this is
the first report on the application of MALDI-TOF MS and PLL
linker to demonstrate stepwise coupling of glycans on to beads.
The complete coupling (m/z 986.8) between GlcNAc4 (m/z 852.9)
andHBAwas also demonstrated in soluble phase (Supplemental
Data). Thus, these results directly prove that HBA-functionalized
beads are well suited for the one-step conjugation of free N-gly-
cans without any derivatization. Furthermore, the HBA-conju-
gated beads allowing UV photocleavage via PLL linker are surely
applicable to facile purification and analysis of glycans from the
crude proteolytic digests. Recently, Nishimura et al. demon-
strated the glycoblotting method for the purification of glycans
from the crude proteolytic digests using aminooxy-functional-
ized solid particles (Nishimura et al., 2004), but the method has
not been applied to GBPs screening yet.216 Chemistry & Biology 15, 215–223, March 2008 ª2008 Elsevier Ltd All rights reserved
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High-Throughput Screening of Glycan-Binding ProteinsFigure 2. Demonstration of Conjugation between Free Glycans and HBA-Functionalized Beads
(A) MALDI spectra of BEBE, N-Boc-HBA-BEBE, and GlcNAc4-HBA-BEBE obtained from after UV photocleavage of photolabile linker (PLL) introduced on to
core-shell-type beads.
(B) Specific fluorescent-conjugated lectin binding image on glycan (ovalbumin)-HBA beads. Concanavalin A (ConA, for terminal a-mannose); wheat germ
agglutinin (WGA, for b-N-acetyl-glucosamine); Arachis hyphgaea lectin (PNA, for terminal b-galactose).
(C) Inhibition test against glycan (ovalbumin)-HBA beads using appropriate monosaccharides (noninhibitory Man and inhibitory GlcNAc) and WGA.To demonstrate the orientation of the immobilized glycans,
specific lectin-binding and monosaccharide inhibition assays
with lectins and monosaccharides were performed. Well-charac-
terized chicken ovalbumin, which predominantly contains termi-
nal-GlcNAc, Gal, and Man and lacks NeuAc (Harvey et al.,
2000), was chosen to demonstrate the oriented immobilization
of the branched N-glycan on to HBA-functionalized beads. The
conjugation between free ovalbumin N-glycans and HBA was
also identified via MALDI-TOF MS analysis, indicating complete
conjugation of the highly branched N-glycans to HBA (Supple-
mental Data). Tetramethylrhodamine-conjugated concanavalin
A (ConA), tetramethylrhodamine-conjugated wheat germ aggluti-
nin (WGA), and Alexa Fluor-conjugated lectin PNA from Arachis
hypogaea specific to branched terminal Man, b-GlcNAc, andChemistry & Biology 1b-Gal, respectively, were incubated with glycan (ovalbumin)-HBA
bead. As expected from the previous studies, theN-glycan (oval-
bumin)-HBA beads showed the highest fluorescence signal with
WGA, which was significantly higher than that with ConA or PNA
(Figure2B). Inaddition, thefluorescencesignalswithWGAagainst
terminal-GlcNAc of glycan (ovalbumin)-HBA beads decreased
with the addition of the N-acetyl-D-glucosamine (GlcNAc), while
D-Mannose did not inhibit the interaction between WGA and gly-
can (ovalbumin)-HBA beads (Figure 2C). Recently, Gru¨n et al.
reported a one-step biotinylation procedure via hydrazide group
to reducing end of carbohydrates (Grun et al., 2006). They directly
demonstrated that sialic acids were not degraded during glycan
derivatization via hydrazide group at elevated temperature.
Thus, the reducing parts of the highly branched N-glycans were5, 215–223, March 2008 ª2008 Elsevier Ltd All rights reserved 217
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High-Throughput Screening of Glycan-Binding ProteinsFigure 3. General Procedure for the Sreening of Glycan-Binding Proteins by Miniature Pig Kidney N-Glycan-Immobilized Beads and Mass
Spectrometry
Glycan-HBA beadwas applied to the identification of miniature pigN-glycan (natural/non-Gal type)-binding proteins from human serum by using the glycan-bind-
ing protein (GBP) screening method.directionally immobilizedon thebeads, and the lectins specifically
recognized the apex of the immobilized ovalbumin N-glycans.
Next, the glycan-HBA beads were applied for screening of pig
kidney N-glycan-binding proteins from human serum that might
trigger antigenic reactions during xenotransplantation as de-
scribed in Figure 3. Although GT-KO pigs have been produced
to overcome hyperacute rejection in pig-to-baboon organ trans-
plantation, there still ensue unknown associations between de-
galactosylated (non-Gal) antigens and human proteins that are
involved in many immune-system functions that are believed to
contribute to acute humoral xenograft rejection and to the adap-
tive immune response (Kuwaki et al., 2005). To release free N-
glycans from a pig kidney, miniature pig kidney membrane
was prepared, as described (Kim et al., 2006b). The membrane
fraction was denatured and subsequently deglycosylated by
PNGase F. The released free N-glycans were purified with a po-
rous graphitic carbon cartridge, qualified (over 100 N-glycans)
and quantified (around 30% contained a-Gal) by using various
mass-spectrometric strategies (Y.-G.K., G.-C.G., David J. Har-
vey, and B.-G.K., unpublished data). To prepare non-Gal N-gly-
cans, pig natural N-glycans were treated with a-galactosidase218 Chemistry & Biology 15, 215–223, March 2008 ª2008 Elsevier Lin vitro. The total pig N-glycan and the non-Gal N-glycan were
individually immobilized on to HBA-functionalized beads. The al-
bumin- and IgG-depleted human serum was first incubated with
HBA-functionalized beads to remove nonspecific-binding pro-
teins, and subsequently the unbound fraction was transferred
to the glycan immobilized beads. After washing with PBS buffer,
the bound proteins were digested overnight with sequencing-
grade trypsin. The tryptic-digested peptides were directly ap-
plied to the LTQ Orbitrap FT MS, and the pig kidney N-glycan-
binding proteins in human serum were identified with SEQUEST
software. In addition, the nonspecific binding fraction was also
tryptic digested and analyzed by LTQ Orbitrap FT MS. As we ex-
pected, most of the nonspecific bound proteins were high-abun-
dant proteins in human serum such as apolipoproteins, a-2mac-
roglobin, and prealbumin (data not shown).
Our sensitive method enabled us to identify several lectin-like
pig natural and non-Gal GBPs, which are known to play a role
in xenograft rejection, and several uncharacterized candidate
GBPs (Table 1 and Figure 4). First, the identification of IgM in
both the natural and non-Gal beads was certainly in good agree-
ment with previous reports (Rood et al., 2005), suggesting thattd All rights reserved
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High-Throughput Screening of Glycan-Binding ProteinsTable 1. Identification of Miniature Pig Kidney Natural/Non-Gal Type N-Glycan-Binding Proteins Using LTQ Orbitrap FT MS
Protein
Natural Pig Kidney N-Glycan Non-Gal Pig Kidney N-Glycan
Max. XCorr
(Charge) Del CN
Abundance of the
Detected Peptideb
Max. XCorr
(Charge) Del CN
Abundance of the
Detected Peptide
Immunoglobulin mu Chaina
KQVGSGVTTDQVQAEAKE 4.72(2) 0.55 7 4.66(2) 0.40 3
KGVALHRPDVYLLPPARE 4.65(3) 0.49 5
KYVTSAPMPEPQAPGRY 2.74(2) 0.47 5
KVSVFVPPRD 2.58(2) 0.49 3
CD40 Ligand: Tumor Necrosis Factor (Ligand) Superfamily Member 5
RQGFYYIYTQVTFCSNRE 3.06(2) 0.42 21 3.08(2) 0.40 19
Complement Component 3
REGVQKEDIPPADLSDQVPDTESETRI 5.92(3) 0.59 3 6.26(3) 0.56 3
RILLQGTPVAQMTEDAVDAERL 6.38(2) 0.59 31 6.32(2) 0.57 33
RSEETKENEGFTVTAEGKG 5.15(2) 0.61 1 5.31(2) 0.61 14
KLSINTHPSQKPLSITVRT 3.99(2) 0.55 8
RIPIEDGSGEVVLSRK 3.73(2) 0.49 2
Complement Component 4B
RVTASDPLDTLGSEGALSPGGVASLLRL 5.50(2) 0.73 2
KMRPSTDTITVMVENSHGLRV 4.82(3) 0.49 1 4.80(2) 0.45 3
KVLSLAQEQVGGSPEKL 4.60(2) 0.55 3
RHLVPGAPFLLQALVRE 3.98(3) 0.39 3
RGPEVQLVAHSPWLKD 3.17(2) 0.43 2
RVGDTLNLNLRA 3.44(2) 0.33 2 3.61(2) 0.32 2
Clusterin Isoform 1: Complement-Associated Protein
RVTTVASHTSDSDVPSGVTEVVVKL 6.31(2) 0.66 25 6.32(2) 0.65 14
KLFDSDPITVTVPVEVSRK 5.26(2) 0.54 51 5.12(2) 0.54 40
KTLLSNLEEAKK 3.65(2) 0.31 25 3.11(2) 0.32 19
RIDSLLENDRQ 3.15(2) 0.32 3 3.18(2) 0.26 3
Chemokine (C-X-C Motif) Ligand 2: GRO2 Oncogene
RLLRVALLLLLLVAASRRA 3.68(3) 0.26 14 3.68(3) 0.27 14
Heparin Cofactor IIa
KHQGTITVNEEGTQATTVTTVGFMPLSTQVRF 3.63(3) 0.41 1
REYYFAEAQIADFSDPAFISKT 3.56(2) 0.57 1
KTLEAQLTPRV 3.00(2) 0.35 3 2.98(2) 0.20 2
RSVNDLYIQKQ 2.67(2) 0.18 1
Coagulation Factor II (Prothrombin)
KSLEDKTERELLESYIDGRI 6.03(3) 0.61 7 5.14(3) 0.62 1
RELLESYIDGRI 2.76(2) 0.37 1 3.32(2) 0.37 3
Platelet Factor 4 Chemokine (C-X-C Motif) Ligand 4a
RHITSLEVIKA 2.93(2) 0.48 3 2.66(2) 0.36 5
Proplatelet Basic Protein (CXCL7)
KGKEESLDSDLYAELRC 3.34(2) 0.52 4 3.74(2) 0.58 3
CD72a
KLSNMENRLKP 1.74(1) 0.16 1
CD209 (DC-SIGN)a
KFWICKKSAASCSRD 2.73(2) 0.10 1
CD14a
RSTLSVGVSGTLVLLQGARG 3.08(2) 0.30 2
Sialic Acid Binding Ig-like Lectin 7a
KSARPAADVGDIGMKD 2.64(2) 0.54 1Chemistry & Biology 15, 215–223, March 2008 ª2008 Elsevier Ltd All rights reserved 219
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High-Throughput Screening of Glycan-Binding ProteinsIgM-related xenograft rejection would be caused by the direct in-
teraction between IgM and a-Gal/non-Gal antigens. In addition,
the identified cytokines and complement components are clearly
involved in acute-phase inflammatory responses (Baldwin et al.,
2003). Interestingly, although the lectin-like activities of pro-
thrombin and proplatelet basic protein have not been character-
ized yet, key proteins in the coagulation cascade of human blood
have been shown to be involved in xenograft rejection (Robson
et al., 2000), for example in the immediate blood-mediated in-
flammatory reaction (IBMIR) that follows pancreatic islet trans-
plantation into the portal vein. Finally, the finding of CD antigens
and sialic acid-binding Ig-like lectin (Siglec) as non-Gal-binding
proteins suggests a possible role of these antigens in rejection
of GT-KO pig organs. Notably, CD209 and CD40 ligand are cos-
timulatory molecules that activate T cells (van Kooyk and Geij-
tenbeek, 2002; Grewal and Flavell, 1996), and CD14 is known
to be a major receptor in the activation of macrophages (Tobias
and Ulevitch, 1993). As shown in Table 1, several proteins bind-
ing to total pig N-glycan (including a-Gal epitopes) were also
found to have affinity to the N-glycan pool without a-Gal anti-
gens. These data may indicate that the proteins found in both
the N-glycan pools are non-Gal-binding proteins, which can be
competing with anti-a-Gal antibodies for xenograft rejection.
However, the human immune responses triggered by the non-
Gal-binding proteins may be later than those by anti-a-Gal
antibodies causing hyperacute rejection.
Taken together, the Gal/non-Gal antigens can activate both
the innate and adaptive immune responses, so the targeting of
these antigenswill be an attractive avenue toward control of graft
Max. XCorr is the highest XCorr value (>1.7, 2.5, 3.0 for singly, doubly, and triply charged peaks, respectively) of the identified peptide. DelCN is the
difference in magnitude between the peptide fit with the highest Xcorr and the peptide fit with the second best Xcorr.
a This marked protein has lectin-like activity.
b The experiment was triplicated to evaluate an abundance of the detected peptide.
Figure 4. Summary of Miniature Pig Kidney
N-Glycan-Binding Proteins Potentially Trig-
gering Xenograft Rejection Mechanism
Natural anti-a-Gal antibodies binding to Gal epi-
topes predominantly initiate hyperacute rejection
of a pig xenograft. In this study, non-Gal-binding
proteins that may play important roles in the acute
humoral xenograft rejection and acute cellular
rejection are identified by highly sensitive GBP
screening method.
rejection using GT-KO pigs as organ do-
nors. Thus, using this GBP screening sys-
tem, we could discover promising candi-
dates of pig kidney N-glycan-binding
proteins whose specific roles and signifi-
cances in xenotransplantation rejection
remain to be fully determined.
SIGNIFICANCE
This study demonstrated that glycan-
HBA beads could be applied to the
screening of GBPs in complex body fluid samples. Our ap-
proach has several important advantages, such as (1) one-
step covalent conjugation of the free reducing part of a
N-glycanwithout any derivatization after isolating the glycan
fromabiological source, (2) a dominant ring-closed reducing
end ofN-glycans, (3) identification of low-abundant proteins
by using highly sensitive mass spectrometry, and (4) high-
throughput screeningofGBPs for thedevelopment of tissue-
or cell-specific glycan library beads. In addition, becausewe
obtained glycans from natural sources released by endo-
glycosidases, the chemical synthesis of branched complex
glycanswas unnecessary to cover the diversity of the glycan
library. The introduction of highly sensitivemass spectrome-
tries such as MALDI-TOF MS and LTQ Orbitrap FT MS en-
abled us to validate stepwise coupling of glycan on to beads
and to identify low-abundant pig glycan-binding proteins ex-
isting in human serum. The identified miniature pig kidney
N-glycan-bindingproteinswill provide aclue for understand-
ingandovercomingadditional barriers to the transplantation
of GT-KO pig organs into humans. Although in this method,
the identifiedGBPscould not exactly pairwith diverseglycan
structures immobilized on to beads, this weakness might be
overcomebya technique suchaselutionwith specificmono-
saccharide-containing buffer. Therefore, this high-through-
put GBP-screening method pioneers the investigation of
the biological roles of GBP-ligand interactions in situ and
should allow the rapid detection of microbial or viral patho-
gens and the screening of glycan-specific GBPs as diagnos-
tic markers of various diseases.220 Chemistry & Biology 15, 215–223, March 2008 ª2008 Elsevier Ltd All rights reserved
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Preparation of N-Glycans from Miniature Pig Kidney Membrane
Proteins and Chicken Ovalbumin
The Institutional Animal Care and Use Committee of the Seoul National Univer-
sity Hospital approved all animal procedures. The specific pathogen-free (SPF)
Chicago Medical School (CMS) miniature pigs were donated from Dr. Yoon
Berm Kim of Rosalind Franklin University of Medicine and Science, CMS
(North Chicago, IL, USA; Setcavage and Kim, 1976). The miniature pig kidney
membrane proteins (36.4 mg ml1) were prepared as described (Kim et al.,
2006b). The fractionated membrane proteins and chicken ovalbumin (20 mg/
ml, Sigma, St. Louis, MO) were denatured at 90C for 10 min for efficient gly-
cosidase cleavage of the N-glycans. After cooling at room temperature, Pep-
tide N-glycosidase F (PNGase-F, Roche, Germany) was treated at 37C for
16 hr. The proteins were precipitated by adding four volumes of cold ethanol
and the mixture was kept in ice for 2 hr. The N-deglycosylated proteins were
centrifuged down to a pellet and the supernatant containing the oligosaccha-
rides was transferred to new eppendorf tubes. The ethanol was evaporated,
and the remaining N-glycans were dissolved by ultrapure water. The released
N-glycans were purified by solid-phase extraction with a porous graphitic car-
bon cartridge (PGC cartridge, Alltech. Associates, Deerfield, IL). First, the car-
tridge waswashedwith 0.1% (v/v) TFA in 80%ACN/H2O (v/v) followed byH2O.
The solution ofN-glycanswas applied to the PGC cartridge. Subsequently, the
cartridge was washed with pure water to remove salts and contaminants in the
sample.N-glycans were eluted twice with 40%ACN in 0.05% (v/v) TFA in H2O.
Each fraction was collected and concentrated by Speed Vac-concentrator
(Ecospin 3180C, Hanil Research and Development, Korea) prior to glycan
immobilization on to the functionalized bead. Before the purified pig kidney
N-glycans were used, they were verified by mass spectrometric approaches
(Y.-G.K., G.-C.G., David J. Harvey, and B.-G.K., unpublished data). The half
of the purified pig kidney N-glycan was used for non-Gal bead production in
vitro by a digestion of Green coffee bean a-galactosidase (five unit/ml, EC
3.2.1.22, specificity for a1-3/4/6-linked galactose, Glyko, Inc., Upper Heyford,
UK) as described (Kim et al., 2006b).
Preparation of HBA-Functionalized Bead and Coupling
Procedure of N-Glycan on to the Bead
The linker and spacer bound resin was synthesized by conventional method of
Fmoc solid phase synthesis as follows. HiCore resin (0.3 mmol g1, 300 mg,
0.09 mmol) was swollen in NMP (N-methyl pyrrolidone, 10 ml, Junsei Chemi-
cal, Co., Tokyo, Japan) and then added to mixture of Fmoc-photolabile linker
(Fmoc-4-[4-(1-aminoethyl)-2-methoxy-5-nitrophenoxy]butyric acid; 94 mg,
0.18mmol, ChemTech, Louisville, KY), BOP (benzotriazol-1-yloxytris(dimethy-
lamino) phosphonium hexafluorophosphate; 80 mg, 0.18 mmol), HOBt (1-
hydroxybenzotriazole; 24 mg, 0.18 mmol), and DIEA (diisopropylethylamine;
63 ml, 0.36 mmol) (Kim et al., 2004). The mixture was stirred at 25C for 2 hr
in a shaking incubator, and the solution containing excess reagents was
filtered out with nitrogen gas. The resin was washed with NMP, DCM (dichloro-
methane, Junsei Chemical, Co., Tokyo, Japan) and MeOH. Fmoc was re-
moved at each cycle with 20% piperidine/NMP (3+17 min), and the resin
was washed with NMP, DCM, and MeOH. Successively, Fmoc-3-aminocap-
roic acid (Fmoc-3-ACA, BeadTech; 64 mg, 0.18 mmol, Seoul, Korea) and
Fmoc-b-alanine (Fmoc-b-Ala; 56 mg, 0.18 mmol, BeadTech, Seoul, Korea)
were alternately coupled on the Fmoc-photolabile linker in the same manner
by two times. And then Boc-4-hydrazinobenzoic acid (Boc-HBA; 56 mg,
0.18 mmol, NeoMPS, San Diego, CA) was introduced on the photolabile linker
and spacer coupled resin by BOP mediated coupling. Finally, Boc group was
removed by adding neat trifluoroacetic acid (TFA, Sigma, St. Louis, MO) at
20C with gently shaking for 2 hr (Uematsu et al., 2005). The resin was
washed with DCM and MeOH after the reagent was filtered out. The prepared
miniature pig kidney N-glycans (natural 4.5 mg, non-Gal 4.5 mg), ovalbumin
glycans (5 mg) and N,N0,N00,N00 0-tetraacetylchitotetraose (2 mg, GlcNAc1-b-
4-GlcNAc1-b-4-GlcNAc1-b-4GlcNAc, Toronto Research Chemicals, Inc.,
North York, ON, Canada) were respectively dissolved by ultrapure water
(350 ml) and acetic acid (150 ml). The each glycan solution was mixed with
HBA-resin and incubated at 25C for 4 hr. After theN-glycan coupling reaction,
the supernatant was discarded, and the N-glycan beads were washed withChemistry & Biology 1dH2O five times. The completion of each coupling reaction was also confirmed
through Kaiser’s ninhydrin test (Supplemental Data; Kaiser et al., 1970).
MALDI-TOF MS
Samples were prepared by mixing an aqueous solution of the sample (0.5 ml)
with a saturated solution of 2,5-dihydroxybenzoic acid (DHB, Sigma, St. Louis,
MO) in acetonitrile (0.3 ml) on the stainless-steel MALDI target and allowing the
mixture to dry under ambient conditions. Matrix-assisted laser desorption/ion-
ization mass spectrometry (MALDI-MS) for the N-glycan coupling validation
was performed with Biflex IV equipped with a 337 nm nitrogen laser (Bruker,
Bremen, Germany). The analyte ions were accelerated at 20 kV under delayed
extraction conditions in the positive reflectron mode. The analytical range of
laser power was adjusted to obtain a good resolution and signal-to-noise ratio.
MALDI-TOF spectra were acquired from m/z 500 to 3500 with an average of
200 shots. Data acquisition and processing were performed with Bruker
X-TOF 5.1.1 and Biotools 2.1 program (Bruker, Bremen, Germany).
Binding Study of Fluorophore-Labeled Lectin on to Chicken
Ovalbumin N-Glycan Bead
The prepared chicken ovalbumin N-glycan bead was incubated with tetrame-
thylrhodamine-conjugated concanavalin A (Con A, 1 mg ml1, Molecular
Probes, Eugene, OR), tetramethylrhodamine-conjugated wheat germ aggluti-
nin (WGA, 1 mg ml1, Molecular Probes, Eugene, OR), and Alexa Fluor-conju-
gated lectin PNA from Arachis hypogaea (1 mg ml1, Molecular Probes,
Eugene, OR) at room temperature for 1 hr. To verify further the N-glycan cou-
pling on to HBA-resin, the inhibition study was carried out through the coincu-
bation with each monosaccharide (D-Mannose and N-acetyl-D-glucosamine,
200 mM, Sigma, St. Louis, MO) and tetramethylrhodamine-conjugated WGA.
After the incubation, the beads were gently washed with PBS buffer three
times. The binding was analyzed by using a confocal laser scanning micro-
scope (LSM5 Pascal, Carl Zeiss, Germany).
Miniature Pig Kidney N-Glycan-Binding Protein
Screening from Human Serum
Albumin and the major subclasses of gamma-globulin (IgG) of human serum
(40 ml, obtained from a healthy male donor, 41 ages) were simultaneously
removed by using ProteoSeek Albumin/IgG Removal Kit (Pierce, Rockford,
IL, USA) according to the manufacturer’s instruction. The human serum was
first incubated with glycan unconjugated beads at 37C for 1 hr, and the
unbound fraction was transferred to glycan immobilized beads. Each glycan
bead (20mg) and serum (100 ml) was incubated at 37C for 1 hr, and the super-
natant was discarded. After mild washing with PBS buffer three times, the
bound proteins were eluted from the beads by elution buffer (0.2 M glycine-
HCl [pH 2.2]) for 10 min and neutralized by neutralizing buffer (1 M Tris[hydrox-
ymethyl]aminomethane-HCl [pH 9.1]). The eluted proteins were denatured at
90C for 10 min. After cooling at room temperature, tryptic digestion was pro-
ceeded by adding 10 ml of trypsin (1 mg ml1, sequencing grade, Promega,
Madison, WI) into each sample, which was then incubated at 37C for 16 hr.
The tryptic digested peptides were dried and dissolved by ultrapure water
for further LTQ mass spectrometric analysis process.
LTQ ESI-MS/MS Analysis
The mass spectrometric analysis of ESI-MS/MS was performed on LTQ Orbi-
trap hybrid Fourier Transform Mass Spectrometer (Thermo Electron Corp,
USA) with nanospray source in positive ion mode at the spray voltage of
1.50 kV. The heated capillary was maintained at a temperature of 200C. For
the MS/MS fragmentation, 35% of normalized collision energy and 2 Da of
isolation width were used. Five scan events were performed. The first full
scan with LTQ was followed by the second full scan with FT orbitrap, and
then three data-dependent MS/MS analyses were performed. The spray tip
for nanospray ion source was made following the method of Gatlin et al.
(1998) with P-2000 laser puller (Shutter Instrument, Novato, CA, USA) to create
a 5micron tip. Samples were infused toC18 (Agilent, USA)-packed spray tip by
usinghomemadehigh-pressurebombwith apressureof 1MPaof nitrogengas.
The loaded samplewas elutedwith gradient from0%Bbuffer to 100%Bbuffer
at a flow rate of 0.3 ml min1 by using Ultimate 3000 2D-nano LC (LC packing,
Netherland). BufferAwaspreparedwithwater/acetonitrile (98/2 [v/v]) and0.1%
formic acid, and buffer B was prepared with water/acetonitrile (20/80 [v/v]) and5, 215–223, March 2008 ª2008 Elsevier Ltd All rights reserved 221
Chemistry & Biology
High-Throughput Screening of Glycan-Binding Proteins0.1% formic acid. Themaximum ion collection timewas set to 10ms, and three
microscans were averaged per scan.
SUPPLEMENTAL DATA
Supplement Data include overall immobilization procedure of glycans on to
beads, MALDI spectra of coupling between N,N0,N00,N00 0-tetraacetylchitote-
traose (GlcNAc4) and 4-hydrazinobenzoic acid, MALDI spectrum and mass
list of coupling between N-glycans from chicken ovalbumin gradeV and 4-hy-
drazinobenzoic acid, exoglycosidase digestion of pig kidney N-glycans, and
MS/MS spectra of the single peptide-based identified CD40 ligand and
Chemokine (C-X-C motif) ligand 2 annotated with masses as well as fragment
assignments, and can be found with this article online at http://www.chembiol.
com/cgi/content/full/15/3/215/DC1/.
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